GlassScriptPhysician profile
Allison Hennigan
NPI 1730335829
$14,820.85
in general payments reported to CMS, 2019-2025
65 companies · $538 in 2025
The $538 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,380 · 2020: $2,113 · 2021: $2,832 · 2022: $2,985 · 2023: $2,367 · 2024: $1,607 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,358 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,358.04 |
| Education | $152.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,516.65 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,334.56 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $1,082.49 | 2019-2023 | Nuplazid, Daybue |
| Teva Pharmaceuticals USA, INC. | $1,036.85 | 2019-2025 | Austedo Xr, Ajovy, Austedo |
| Neurocrine Biosciences, INC. | $832.63 | 2019-2024 | Ingrezza, Ongentys |
| Biogen, INC. | $637.00 | 2019-2025 | Tysabri, Vumerity |
| Lilly USA, LLC | $550.62 | 2019-2025 | Emgality, Kisunla, Amyvid |
| Ucb, INC. | $471.05 | 2019-2022 | |
| Emd Serono, INC. | $463.28 | 2019-2025 | Mavenclad |
| Amgen INC. | $460.48 | 2019-2024 | Uplizna |
| Allergan, INC. | $458.00 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $440.33 | 2019-2024 | Rytary |
| Sk Life Science, INC. | $431.66 | 2020-2024 | |
| Acorda Therapeutics, INC | $333.31 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $329.58 | 2019-2021 |
Show all 65 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Hennigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.